Kapil Dhingra, M.D., founded KAPital Consulting, LLC, in 2008, a company dedicated to helping biotechnology, pharmaceutical and diagnostic companies realize the clinical and commercial advances in oncology. From 1999 to 2008, Dr. Dhingra served in various positions at Hoffmann-La Roche, including Vice President, Head, Oncology Disease Biology Leadership Team, and Head, Oncology Clinical Development. Prior to joining Roche, he worked at Eli Lilly and Company. Dr. Dhingra held faculty appointments, at various stages of his career, at The University of Texas M.D. Anderson Cancer Center, at Indiana University School of Medicine and at Memorial Sloan Kettering Cancer Center in New York. He serves on the Boards of Directors and as an advisor to several biotechnology and pharmaceutical companies and healthcare organizations. Dr. Dhingra holds an MBBS (equivalent to US MD) degree from the All India Institute of Medical Sciences (AIIMS), and has performed postgraduate work at the AIIMS, the Lincoln Medical and Mental Health Center (New York Medical College) and Emory University School of Medicine, Atlanta GA.

 Biotechnology